Bicara Therapeutics Inc. - Common Stock, $0.0001 par value per share (BCAX)

Q: What does CUSIP 055477103 represent in this 13F holders report?

CUSIP 055477103 is the security identifier for BCAX - Bicara Therapeutics Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held BCAX - Bicara Therapeutics Inc. - Common Stock, $0.0001 par value per share in Q1 2025?

92 institutional investors reported BCAX - Bicara Therapeutics Inc. - Common Stock, $0.0001 par value per share for Q1 2025. Use the holders table for investor-level position and value details.

CUSIP: 055477103

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 66,052,271
Total 13F shares: 48,567,553
Share change: +1,838,796
Total reported value: $633,357,650
Price per share: $13.03
Number of holders: 92
Value change: +$9,523,679
Number of buys: 52
Number of sells: 37

Quarterly Holders Quick Answers

What is CUSIP 055477103?
CUSIP 055477103 identifies BCAX - Bicara Therapeutics Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2025
Previous quarter: Q4 2024

Recent filing periods for CUSIP 055477103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Top shareholders of BCAX - Bicara Therapeutics Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	11%	6,955,993	$121,173,398	—	31 Dec 2024	13F
Biocon Ltd	3/4/5	10%+ Owner	— class O/S missing	5,523,897	$73,155,178	—	16 Sep 2024	3/4/5
Siren, L.L.C.	13F	Individual	5%	3,272,827	$57,012,646	—	31 Dec 2024	13F
Red Tree Management, LLC	13F	Company	4.8%	3,170,509	$55,230,267	—	31 Dec 2024	13F
TPG GP A, LLC	13F 3/4/5	Company · Former 10% Owner	4.6%	3,010,425	$52,441,604	—	31 Dec 2024	13F 3/4/5
Omega Fund Management, LLC	13F	Company	3.3%	2,204,650	$38,405,003	—	31 Dec 2024	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	3.3%	2,175,265	$37,893,116	—	31 Dec 2024	13F
FMR LLC	13F 3/4/5	Company · Other*	3.2%	2,117,088	$36,879,673	—	31 Dec 2024	13F 3/4/5
BRAIDWELL LP	13F	Company	3%	2,000,659	$34,851,480	—	31 Dec 2024	13F
Deep Track Capital, LP	13F	Company	3%	2,000,000	$34,840,000	—	31 Dec 2024	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	2.7%	1,795,174	$31,271,931	—	31 Dec 2024	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.3%	1,547,180	$26,953,000	—	31 Dec 2024	13F
James E. Flynn	3/4/5	Possible Members of 10% Group, 10%+ Owner	— class O/S missing	1,795,174	$23,774,208	—	17 Sep 2024	3/4/5
Fairmount Funds Management LLC	13F	Company	1.9%	1,284,169	$22,370,224	—	31 Dec 2024	13F
BlackRock, Inc.	13F	Company	1.9%	1,261,601	$21,977,089	—	31 Dec 2024	13F
VANGUARD GROUP INC	13F	Company	1.7%	1,090,528	$18,996,998	—	31 Dec 2024	13F
FIL Ltd	13F 3/4/5	Company · Other*	1.5%	1,013,853	$17,661,319	—	31 Dec 2024	13F 3/4/5
Foresite Capital Management VI LLC	13F	Company	1.4%	950,000	$16,549,000	—	31 Dec 2024	13F
Blackstone Inc.	13F	Company	1.4%	913,060	$15,905,505	—	31 Dec 2024	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.3%	863,846	$15,008,926	—	31 Dec 2024	13F
BAKER BROS. ADVISORS LP	13F	Company	1.3%	833,333	$14,516,661	—	31 Dec 2024	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.2%	821,264	$14,306,419	—	31 Dec 2024	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.1%	757,968	$13,203,803	—	31 Dec 2024	13F
Vestal Point Capital, LP	13F	Company	1.1%	710,000	$12,368,200	—	31 Dec 2024	13F
ACORN CAPITAL ADVISORS, LLC	13F	Company	0.97%	643,381	$11,207,697	—	31 Dec 2024	13F
Aisling Capital Management LP	13F	Company	0.86%	568,919	$9,910,569	—	31 Dec 2024	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.71%	466,642	$8,130,571	—	31 Dec 2024	13F
Rock Springs Capital Management LP	13F	Company	0.68%	445,975	$7,768,885	—	31 Dec 2024	13F
MORGAN STANLEY	13F	Company	0.61%	402,918	$7,018,832	—	31 Dec 2024	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.58%	385,406	$6,713,773	—	31 Dec 2024	13F
First Turn Management, LLC	13F	Company	0.52%	346,170	$6,030,281	—	31 Dec 2024	13F
STATE STREET CORP	13F	Company	0.46%	304,731	$5,308,414	—	31 Dec 2024	13F
ORBIMED ADVISORS LLC	13F	Company	0.45%	298,301	$5,196,403	—	31 Dec 2024	13F
Woodline Partners LP	13F	Company	0.42%	275,692	$4,802,555	—	31 Dec 2024	13F
UBS Group AG	13F	Company	0.3%	200,407	$3,491,090	—	31 Dec 2024	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.27%	179,749	$3,131,228	—	31 Dec 2024	13F
NORTHERN TRUST CORP	13F	Company	0.24%	159,043	$2,770,529	—	31 Dec 2024	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.24%	156,784	$2,731,177	—	31 Dec 2024	13F
Boxer Capital Management, LLC	13F	Company	0.2%	135,000	$2,351,700	—	31 Dec 2024	13F
DEUTSCHE BANK AG\	13F	Company	0.17%	112,476	$1,959,332	—	31 Dec 2024	13F
DAFNA Capital Management LLC	13F	Company	0.16%	105,500	$1,837,810	—	31 Dec 2024	13F
TD ASSET MANAGEMENT INC	13F	Company	0.16%	102,420	$1,784,156	—	31 Dec 2024	13F
NORGES BANK	13F	Company	0.11%	70,000	$1,219,400	—	31 Dec 2024	13F
MARSHALL WACE, LLP	13F	Company	0.1%	67,733	$1,179,910	—	31 Dec 2024	13F
JPMORGAN CHASE & CO	13F	Company	0.1%	64,740	$1,127,771	—	31 Dec 2024	13F
Bank of New York Mellon Corp	13F	Company	0.06%	40,268	$701,468	—	31 Dec 2024	13F
Skandinaviska Enskilda Banken AB (publ)	13F	Company	0.06%	38,035	$646,595	—	31 Dec 2024	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.05%	33,677	$586,653	—	31 Dec 2024	13F
BARCLAYS PLC	13F	Company	0.05%	30,107	$524,464	—	31 Dec 2024	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.04%	29,138	$507,584	—	31 Dec 2024	13F

Institutional Holders of Bicara Therapeutics Inc. - Common Stock, $0.0001 par value per share (BCAX) as of Q1 2025

As of 31 Mar 2025, Bicara Therapeutics Inc. - Common Stock, $0.0001 par value per share (BCAX) was held by 92 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,567,553 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., FMR LLC, Siren, L.L.C., RED TREE MANAGEMENT, LLC, TPG GP A, LLC, Vestal Point Capital, LP, Omega Fund Management, LLC, BRAIDWELL LP, Deep Track Capital, LP, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 93 institutional shareholders reporting positions in this security for the Q1 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders

Q1 2025 holders

Holder diff

Investor	Q4 2024 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q4 2024 Value $	Q1 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.